FDA Inspection 1118521 — Hassman Research Institute
The FDA completed an inspection of Hassman Research Institute on Jan 8, 2020 in Berlin, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 8, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Berlin, NJ (United States)
Additional details
Clinical BA/BE